Valuation: Masimo Corporation

Market Cap 9.42B 8.16B 7.71B 6.99B 13.12B 903B 13.21B 91.99B 35.44B 458B 35.39B 34.61B 1,462B P/E 2024
-29.9x
P/E 2025 -45.5x
Enterprise Value 9.83B 8.52B 8.05B 7.3B 13.68B 942B 13.79B 95.96B 36.97B 478B 36.92B 36.1B 1,525B EV / Sales 2024
4.7x
EV / Sales 2025 4.75x
Free-Float
66.12%
Yield 2024 *
-
Yield 2025 -
1 day+0.01%
6 months+2.54%
Current year+38.36%
Current year 125.94
Extreme 125.94
179.99
1 year 125.94
Extreme 125.94
179.99
3 years 75.22
Extreme 75.22
194.88
5 years 75.22
Extreme 75.22
305.21
10 years 53.78
Extreme 53.78
305.21
Manager TitleAgeSince
President - 2026-08-02
Chief Tech/Sci/R&D Officer - -
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member - 2026-06-09
Date Insider Type Main position Quantity % Market Cap. Importance
6/10/26 Issuer sale

Responsable ventes & marketing

-13,318 0.0254%
4/23/26 Exercice

Director

3,569 0.0068%
4/23/26 Exercice

Director

3,569 0.0068%
Change 5-day change 1-year change 3-year change Capi.($)
+0.01%-.--%+22.05%+75.82% 9.42B
-0.45%-1.16%+16.76%+18.17% 12.6B
+0.04%-2.26%+12.42%+16.89% 6.64B
+0.18%-5.48% - - 6.18B
+0.06%-4.94%+20.93%+9.00% 5.58B
-1.23%+0.98%-18.28%+42.04% 5.15B
+2.24%+2.04%-33.26%-23.26% 3.78B
-0.43%-9.98%+32.92%-17.69% 1.89B
0.00%+6.83%-4.39%+164.64% 1.77B
+1.60%-2.25%+48.32%-16.80% 1.59B
Average +0.20%-1.56%+10.83%+29.87% 5.46B
Weighted average by Cap. +0.00%-1.36%+10.93%+30.27%

Financials

2024 2025
Net sales 2.09B 1.81B 1.71B 1.55B 2.92B 201B 2.94B 20.44B 7.88B 102B 7.87B 7.69B 325B 1.53B 1.32B 1.25B 1.13B 2.13B 146B 2.14B 14.91B 5.74B 74.25B 5.74B 5.61B 237B
Net income -305M -264M -250M -226M -424M -29.22B -428M -2.98B -1.15B -14.83B -1.15B -1.12B -47.29B -152M -131M -124M -112M -211M -14.52B -212M -1.48B -570M -7.37B -569M -556M -23.5B
Net Debt 668M 579M 547M 496M 931M 64.08B 937M 6.53B 2.51B 32.51B 2.51B 2.46B 104B 407M 353M 333M 302M 567M 39.01B 571M 3.97B 1.53B 19.79B 1.53B 1.49B 63.13B
Logo Masimo Corporation
Masimo Corporation is a global medical technology company that develops and produces a wide range of monitoring technologies, including measurements, sensors, patient monitors, automation and connectivity solutions. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. It primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.
Employees
2,200
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BB
  1. Stock Market
  2. Stocks
  3. MASI Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!